Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers-Reference-Cited by-同舟云学术

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

Published:2014-01-24 Issue:3 Volume:143 Page:579-586
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kotsopoulos Joanne, ,Lubinski Jan,Moller Pal,Lynch Henry T.,Singer Christian F.,Eng Charis,Neuhausen Susan L.,Karlan Beth,Kim-Sing Charmaine,Huzarski Tomasz,Gronwald Jacek,McCuaig Jeanna,Senter Leigha,Tung Nadine,Ghadirian Parviz,Eisen Andrea,Gilchrist Dawna,Blum Joanne L.,Zakalik Dana,Pal Tuya,Sun Ping,Narod Steven A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2823-4.pdf

Reference32 articles.

1. Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

2. Narod SA (2010) BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 7(12):702–707

3. Kotsopoulos J et al (2005) Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control 16(6):667–674

4. Gronwald J et al (2006) Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 95(2):105–109

5. Chang-Claude J et al (1997) Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123(5):272–279

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of new models for primary dysmenorrhea treatment: low-power visible-light-activated photodynamic therapy and oral contraceptives;Frontiers in Medicine;2024-05-01

2. Debate on the oncologic potential of sex steroid preparations;V.F.Snegirev Archives of Obstetrics and Gynecology;2023-12-19

3. Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes;Oncology in Clinical Practice;2023-10-25

4. Femmes à très haut risque de cancer du sein : contraception, traitement hormonal substitutif et dépistage personnalisé;Gynécologie Obstétrique Fertilité & Sénologie ;2023-05

5. Modifiable risk factors in women at high risk of breast cancer: a systematic review;Breast Cancer Research;2023-04-24